Gene therapies have seen a drop in investor interest lately. Despite this, Kriya Therapeutics seems to be attracting funds in ...

Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small ...

Discover how in some communities around the world, the prevalence of rare diseases is higher due to factors like cousin ...

As the release of a CRL declining Lykos' therapy generates a strong reaction from MAPS, delve into what this new transparency ...

Learn how multichain biotherapeutics overcome manufacturing challenges with advanced expression vector design.

As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix's, an established company ...

Once thought to be under control, yellow fever is making an alarming comeback, and the numbers are climbing. With treatment ...

Kriya Therapeutics, Strand Therapeutics, and Minghui Pharmaceutical bagged the biggest biotech funding rounds overall in ...

Aelix Therapeutics is a clinical-stage biotech company based in Barcelona, in the northeast of Spain. It is a spin-off of IrsiCaixa, a Catalan organization founded to address the HIV/AIDS epidemic, ...

As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines.

mRNA vaccine research will be stripped of $500 million in funding from the U.S. Department of Health and Human Services (HHS). The agency listed 22 projects that will be affected, many of which are ...

Nature writes the best horror stories – In The New York Times’ recent piece, the return of the screwworm, a flesh‑eating parasite once eradicated from the U.S. Indeed, cattle ranchers are once again ...